MarketInOut Stock Screener Log In | Sign Up

Bavarian Nordic A/S

XETRA • Healthcare • Biotechnology • Quote as of 10/27/2026 17:35
Bavarian Nordic A/S stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeXETRA
Market Capitalization2,502.18 mln
Float64.56 mln
Earnings Date11/13/2026

EPS

2.61
Solid

P / E

12.97
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.95
Caution advised

Relative Strength

94 / 100
Top performer

Debt / Equity

0.01
Debt-free

Business Description

Founded in 1992 and based in Hellerup, Denmark, Bavarian Nordic is a vaccine company that protects people against a range of serious infectious diseases. Its products include vaccines for smallpox, monkeypox, rabies, tick-borne encephalitis, cholera, and typhoid fever, sold under well-known brand names across the United States, Europe, Asia, and beyond. The company is also running clinical trials on a new vaccine aimed at combating dangerous encephalitis viruses.

Key Fundamentals

EPS2.61
P/E12.97
ROE12.05
ROIC7.29
ROA10.59
Interest Cover66.23
EBITDA, mln365
EV / EBITDA5.28
EV / EBIT7.21
Revenue, mln838
EV / Revenue2.30

Quote Details

Last 34.44
Change 1.02 (3.05%)
Open 34.22
Volume 327
Turnover 11,262
Average Volume 340.29

Financial Ratios

Pre-Tax Profit Margin32
Current Ratio6.53
Price / Book1.26
Price / Tangible Book2.23
Price / Free Cash Flow13.79
Debt / Equity0.01
Price / Sales2.69

Financial Strength

Altman Z-Score9.12
Piotroski F-Score 6 / 9
Beneish M-Score-1.95
Price to Intrinsic Value0.84
Price to Graham Number1.06
Shiller PE Ratio47.22

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.22% 97 / 100   
1 Month 17.78% 98 / 100   
2 Months 36.78% 98 / 100   
6 Months 33.9% 95 / 100   
1 Year 11.13% 52 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog